Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $38.0300 (0.18%) ($38.0300 - $38.0300) on Wed. Jul. 21, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.77% (three month average) | RSI | 47 | Latest Price | $38.0300(0.18%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX advances 0.5% a day on average for past five trading days. | Weekly Trend | TGTX declines -2.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(68%) ARKG(63%) ARKK(59%) IWO(59%) IBB(58%) | Factors Impacting TGTX price | TGTX will decline at least -1.385% in a week (0% probabilities). VIXM(-46%) VXX(-38%) UUP(-19%) UNG(-4%) TLT(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.385% (StdDev 2.77%) | Hourly BBV | 1.4 () | Intraday Trend | 0% | | | |
|
Resistance Level | $38.48 | 5 Day Moving Average | $37.36(1.79%) | 10 Day Moving Average | $38.03(0%) | 20 Day Moving Average | $38.48(-1.17%) | To recent high | -14.6% | To recent low | 17.2% | Market Cap | $4.816b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |